(Q35900223)

11 August 2017

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system (English)

1 reference

11 August 2017

Bacteroides fragilis

1 reference

1 reference

Zabinski RA

1

1 reference

11 August 2017

Vance-Bryan K

2

1 reference

11 August 2017

Krinke AJ

3

1 reference

11 August 2017

Walker KJ

4

1 reference

11 August 2017

Moody JA

5

1 reference

11 August 2017

Rotschafer JC

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

37

1 reference

11 August 2017

11

1 reference

11 August 2017

2454-2458

1 reference

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8285633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fluoroquinolone antimicrobial agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8285633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.11.2454

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8285633

1 reference